KR20030009374A - 시프로플록사신의 1일 1회 투여를 위한 경구 투여용제어된 전달 시스템 - Google Patents

시프로플록사신의 1일 1회 투여를 위한 경구 투여용제어된 전달 시스템 Download PDF

Info

Publication number
KR20030009374A
KR20030009374A KR1020027011441A KR20027011441A KR20030009374A KR 20030009374 A KR20030009374 A KR 20030009374A KR 1020027011441 A KR1020027011441 A KR 1020027011441A KR 20027011441 A KR20027011441 A KR 20027011441A KR 20030009374 A KR20030009374 A KR 20030009374A
Authority
KR
South Korea
Prior art keywords
ciprofloxacin
formulation
xanthan gum
drug
sodium alginate
Prior art date
Application number
KR1020027011441A
Other languages
English (en)
Korean (ko)
Inventor
탈와르나레쉬
스타니포쓰존엔.
램팔아속
무케르지구어
비솨나탄바드리엔.
케라브리즈
Original Assignee
랜박시 래보러터리스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 랜박시 래보러터리스 리미티드 filed Critical 랜박시 래보러터리스 리미티드
Publication of KR20030009374A publication Critical patent/KR20030009374A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020027011441A 2000-03-03 2001-02-28 시프로플록사신의 1일 1회 투여를 위한 경구 투여용제어된 전달 시스템 KR20030009374A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03
US09/517,887 2000-03-03

Publications (1)

Publication Number Publication Date
KR20030009374A true KR20030009374A (ko) 2003-01-29

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027011441A KR20030009374A (ko) 2000-03-03 2001-02-28 시프로플록사신의 1일 1회 투여를 위한 경구 투여용제어된 전달 시스템

Country Status (31)

Country Link
EP (1) EP1263409A1 (et)
JP (1) JP2003525229A (et)
KR (1) KR20030009374A (et)
CN (1) CN1420763A (et)
AP (2) AP2001002084A0 (et)
AR (1) AR032614A1 (et)
AU (1) AU3589701A (et)
BG (1) BG107055A (et)
BR (1) BR0108958A (et)
CA (1) CA2400950A1 (et)
CZ (1) CZ20022883A3 (et)
DO (1) DOP2001000130A (et)
EA (1) EA200200914A1 (et)
EC (1) ECSP013952A (et)
EE (1) EE200200497A (et)
GT (1) GT200100033A (et)
HN (1) HN2001000038A (et)
HR (1) HRP20020715A2 (et)
HU (1) HUP0204417A3 (et)
IL (1) IL151553A0 (et)
IS (1) IS6532A (et)
MX (1) MXPA02008568A (et)
NO (1) NO20024108L (et)
NZ (1) NZ520927A (et)
OA (1) OA12381A (et)
PE (1) PE20011113A1 (et)
PL (1) PL365071A1 (et)
SK (1) SK12542002A3 (et)
WO (1) WO2001064183A1 (et)
YU (1) YU66202A (et)
ZA (1) ZA200206764B (et)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1745775B1 (en) 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
DE602006012962D1 (de) * 2006-07-19 2010-04-29 Tabuk Pharmaceutical Mfg Co Pharmazeutische Zubereitungen von Ciprofloxacin
EP3247384B1 (en) 2015-01-14 2023-10-04 The Regents of the University of Colorado, a body corporate In vitro method of diagnosis of type 1 diabetes with insulin mimotopes
CA3015400A1 (en) * 2016-02-23 2017-08-31 Matripharm International Inc. Dual-rate release formulation with high drug loading
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (zh) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 一种乳酸环丙沙星泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE19839057A1 (de) * 1998-08-28 2000-03-02 Koch Berthold Spülluft-Regler für eine Trockenvorrichtung für Druckluft
NZ510487A (en) * 1998-09-14 2003-04-29 Ranbaxy Lab Ltd Pharmaceutical composition comprising ciprofloxacin, sodium alginate, xanthan gum and a cross-linker polymer in a tablet or capsule form

Also Published As

Publication number Publication date
EP1263409A1 (en) 2002-12-11
BG107055A (bg) 2003-06-30
HUP0204417A3 (en) 2005-03-29
DOP2001000130A (es) 2004-03-31
YU66202A (sh) 2005-09-19
EA200200914A1 (ru) 2003-02-27
AP2002002627A0 (en) 2002-09-30
GT200100033A (es) 2001-10-25
HUP0204417A2 (en) 2003-05-28
AR032614A1 (es) 2003-11-19
CZ20022883A3 (cs) 2003-04-16
NZ520927A (en) 2003-06-30
IS6532A (is) 2002-08-28
CN1420763A (zh) 2003-05-28
JP2003525229A (ja) 2003-08-26
ECSP013952A (es) 2002-04-23
PL365071A1 (en) 2004-12-27
NO20024108D0 (no) 2002-08-28
EE200200497A (et) 2004-02-16
CA2400950A1 (en) 2001-09-07
WO2001064183A1 (en) 2001-09-07
NO20024108L (no) 2002-10-25
AU3589701A (en) 2001-09-12
HRP20020715A2 (en) 2004-12-31
PE20011113A1 (es) 2001-10-14
ZA200206764B (en) 2003-03-04
IL151553A0 (en) 2003-04-10
HN2001000038A (es) 2005-03-23
SK12542002A3 (sk) 2003-05-02
BR0108958A (pt) 2003-09-30
AP1485A (en) 2005-10-31
AP2001002084A0 (en) 2001-03-31
MXPA02008568A (es) 2003-02-24
OA12381A (en) 2004-09-06

Similar Documents

Publication Publication Date Title
KR100642110B1 (ko) 시간적 및 공간적 조절을 제공하는 경구투여용 제어 약물 전달 시스템
EP1107741B1 (en) Orally administered controlled drug delivery system providing temporal and spatial control
EP1008354B1 (en) Immediately disintegrable medicinal compositions
US6899896B2 (en) Hydrogel-driven layered drug dosage form
US20100098759A1 (en) Controlled-release preparation containing cilostazol and process for the preparation thereof
JPH07558B2 (ja) モピダモール製剤
US20020119192A1 (en) Controlled release formulations for oral administration
KR20030009374A (ko) 시프로플록사신의 1일 1회 투여를 위한 경구 투여용제어된 전달 시스템
AU2006201553A1 (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin
US20080206338A1 (en) Controlled release formulations of an alpha-adrenergic receptor antagonist

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application